Clinical response after laparoscopic fenestration of symptomatic hepatic cysts: a systematic review and meta-analysis
Executive Summary
Laparoscopic fenestration—also referred to as deroofing or unroofing—is a highly effective surgical intervention for patients suffering from symptomatic hepatic cysts. Based on a systematic review and meta-analysis of 62 studies involving 1,314 patients, the procedure yields a pooled symptomatic relief rate of 90.2%. While the overall safety profile is favorable, with a low symptomatic recurrence rate of 9.6% and a major complication rate of 3.3%, outcomes vary significantly depending on the underlying pathology.
Patients with Polycystic Liver Disease (PLD) face markedly higher risks and lower long-term efficacy compared to those with solitary cysts. In the PLD subgroup, symptomatic recurrence rises to 33.7%, and the complication rate reaches 29.3%. Furthermore, common surgical adjuncts such as omentopexy and concomitant cholecystectomy do not appear to significantly impact recurrence or complication rates. Consequently, while laparoscopic fenestration is a primary treatment for large solitary cysts, the threshold for its use in PLD patients should be higher due to limited long-term benefits.
Overview of Systematic Review Methodology
The analysis synthesized data from 62 studies published between 1994 and 2017, covering a total patient population of 1,314.
Patient Demographics: The study population was 74% female with a median age of 58.7 years.
Cyst Characteristics: The average preoperative cyst diameter was 11.9 cm.
Study Quality: The median Newcastle–Ottawa scale (NOS) score was 6 out of 9, indicating moderate methodological quality.
Follow-up: The median follow-up duration was 30 months, which is critical as the mean time to symptomatic recurrence was identified as 16.1 months.
Clinical Efficacy and Long-Term Outcomes
The primary goal of laparoscopic fenestration is the alleviation of symptoms such as pain, nausea, and dyspnea caused by large cysts (typically >5 cm).
Symptomatic Relief: 90.2% of patients experienced full or partial relief immediately following surgery.
Symptomatic Recurrence: The overall pooled recurrence rate was 9.6%.
Reintervention Rate: Approximately 7.1% of patients required a second intervention for the same cyst.
Timeline of Recurrence:
Mean time to recurrence: 16.1 months.
Mean time to reintervention: 22.1 months.
Safety Profile and Complications
Laparoscopic fenestration is generally considered safe, though it carries specific perioperative risks.
General Safety Metrics
Conversion to Open Surgery: Necessary in 4.5% of cases, primarily due to intra-operative bleeding, extensive adhesions, or difficult cyst positioning.
Procedure-Related Mortality: Pooled at 1.0%, though this figure is largely driven by a single reported death in a small cohort of PLD patients.
Hospital Stay: The median stay was 5.0 days.
Post-Operative Complications
The overall post-operative complication rate was 10.8%. These complications primarily included bile leakage, ascites, pleural effusion, and infections. Using the Clavien–Dindo classification, complications were categorized as follows:
Minor (Grade I-II): 71.3% of reported complications.
Major (Grade III-V): 28.7% of reported complications (overall pooled estimate: 3.3%).
Comparative Analysis: Solitary Cysts vs. Polycystic Liver Disease (PLD)
The most significant finding of the analysis is the disparate outcomes between patients with simple solitary cysts and those with PLD.
The higher recurrence in PLD is attributed to the different natural history of the disease; while fenestration addresses a specific large cyst, the underlying genetic condition causes the total liver volume to increase by approximately 1.8% every 6–12 months, eventually overtaking the volume-curtailing effects of the surgery.
Evaluation of Surgical Techniques and Adjuncts
The core surgical technique involves laparoscopy, fluid aspiration, and wide deroofing of the cyst wall near the transition to normal hepatic parenchyma.
Omentopexy
Some surgeons apply omental tissue (omentopexy) into the residual cyst cavity to prevent fluid re-accumulation.
Efficacy: The analysis found no significant difference in recurrence rates between those who received omentopexy (5.7%) and those who did not (8.7%).
Safety: There was no significant difference in complication rates (11.0% with vs. 8.4% without).
Concomitant Cholecystectomy
Often performed when cysts are adjacent to the gallbladder or when gallstones are present.
Efficacy: Symptomatic recurrence was 7.3% with cholecystectomy vs. 9.3% without.
Safety: Complication rates were 7.6% with cholecystectomy vs. 9.1% without.
Alternatives and Future Directions
Percutaneous Aspiration Sclerotherapy
A valid alternative to surgery, this involves draining the cyst via catheter and injecting a sclerosing agent (e.g., ethanol).
Pros: Less invasive; effective in reducing symptoms in 72–100% of cases.
Cons: Takes longer (up to 26 weeks) to reach full effect as fluid reaccumulates initially before regressing.
Technical Innovations
While standard laparoscopy remains the baseline, the review noted emerging use of:
Robot-assisted fenestration for giant cysts.
Single-incision laparoscopic surgery (SILS).
Indocyanine green (ICG) fluorescent imaging to identify bile duct communication and prevent injuries.
Ablation techniques (argon beam coagulation or ethanol sclerotherapy) used during deroofing to further reduce recurrence, though evidence remains limited.
Conclusion
Laparoscopic fenestration stands as a robust treatment for symptomatic simple hepatic cysts. However, its application in the PLD population is tempered by a significantly higher risk of complications and recurrence. For these patients, the procedure offers limited long-term efficacy, and clinical decision-making should prioritize higher thresholds for surgical intervention.
